Allogene Therapeutics, Inc. Common Stock (ALLO) is a publicly traded Healthcare sector company. As of August 15, 2026, ALLO trades at $2.04 with a market cap of $714.47M and a P/E ratio of -3.07. ALLO moved +3.54% today. Year to date, ALLO is +51.85%; over the trailing twelve months it is +91.59%. Its 52-week range spans $0.86 to $4.46. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces ALLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ALLO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.04 |
| Market Cap | $714.47M |
| P/E Ratio | -3.07 |
| EPS | $-0.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.46 |
| 52-Week Low | $0.86 |
| Volume | 4.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.64M |
| Net Income | $-165.49M |
| Gross Margin | 0.00% |
6 analysts cover ALLO: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.